B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Prolonged ERK activation events

REACTOME PATHWAY
Reactome: R-HSA-1698937 genes30 compounds

The Prolonged ERK activation events pathway (Reactome ID: R-HSA-169893) involves 7 genes and is affected by 30 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

BRAFMAP2K1MAP2K2MAPK1MAPK3NTRK1YWHAB

Compounds Affecting Prolonged ERK activation events

#CompoundTargets HitStudies
1Sorafenib300
2pd980597
3trametinib296
4Dasatinib299
5Axitinib298
6Vemurafenib298
7plumbagin [Supplementary Concept]300
8alsterpaullone12
9kenpaullone8
10sp600125117
11isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
12withaferin300
13Quercetin300
14tyrphostin ag 14784
15Clotrimazole296
16fisetin78
17Progesterone299
182-Chloroadenosine 2-Chloroadenosine.300
19Benzalkonium Compounds299
20Calcimycin216
21daph2
22Diphenhydramine14
23ha10044
24Lithocholic Acid300
25Loratadine296
26trequinsin hydrochloride1
27arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from300
28myricetin-3-O-galactopyranoside [Supplementary Concept]300
29Crizotinib298
30pictilisib25

About the Prolonged ERK activation events Pathway

The Prolonged ERK activation events pathway is catalogued in Reactome (ID: R-HSA-169893) and involves 7 genes. In the BiohacksAI corpus, 30 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BRAF, MAP2K1, MAP2K2, MAPK1, MAPK3.